emapalumab-lzsg (gamifant) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class
AACT Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$5187.4600 - $13420.5500

VA FSS

$6579.1000 - $16630.5000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
emapalumab 10 mg / 2 mL (2 mL INJECTION) $5187.4600 VA Big4
  • GAMIFANT (1)
    		•  Sobi, Inc.
    emapalumab 10 mg / 2 mL (2 mL INJECTION) $6579.1000 VA FSS
  • GAMIFANT (1)
    		•  Sobi, Inc.
    emapalumab 50 mg / 10 mL (10 mL INJECTION) $13420.5500 VA Big4
  • GAMIFANT (1)
    		•  Sobi, Inc.
    emapalumab 50 mg / 10 mL (10 mL INJECTION) $16630.5000 VA FSS
  • GAMIFANT (1)
    		•  Sobi, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue